Privia Health Group (PRVA) Stock: Buy, Sell, or Hold?

PRVA - Privia Health Group, Inc. Common Stock

SERVICES-HEALTH SERVICES
$22.47
-0.46 (-2.01%) ▼
5d: +3.69%
30d: +15.47%
90d: -10.01%
WAIT
LOW Confidence
Protect Your PRVA Gains
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026 13d

Get Alerted When PRVA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: PRVA shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$38.55
Based on 11.9% avg growth
INTRINSIC VALUE TODAY
$23.94
6.1% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.8x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: PRVA is currently trading at $22.47, which is considered extended relative to its 30-day fair value range of $19.58 to $21.12. The stock's valuation (Forward PE: 21.1) is in line with its historical norms (20.8). At these levels, the market is pricing in 0.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, PRVA is in a downtrend. The price is approaching resistance at $23.13. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: PRVA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.47 (+40.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $19.58 - $21.12
Company Quality Score 30/100 (SELL)
Volume Confirmation HIGH
Confidence Score 24.8%

Protect Your Profits

Holding PRVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range (+6.4% above its trading range)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 40.1% below Wall St target ($31.47)
  • NEUTRAL: Market pricing in 0.6% annual earnings growth - fairly valued
  • WARNING: Composite score 30/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $19.58 - $21.12
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $20.09
Resistance Level $23.13
Current Trend Downtrend
Technical data as of Oct 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 21.14
Wall Street Target $31.47 (+40.1%)
Revenue Growth (YoY) 21.4%
Earnings Growth (YoY) 250.0%
Profit Margin 1.2%
Valuation Premium vs History +0.6% premium
PE vs Historical 21.1 vs 20.8 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +0.6% (market-implied from PE analysis)
1-Year Target $22.60 (+1%)
2-Year Target $22.74 (+1%)
3-Year Target $22.88 (+2%)
3-Yr Target (if PE normalizes) (PE: 21→21) PE COMPRESSION $22.51 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 21.1, Growth: 19.8%) $38.68 (+72%)
Base: (SPY PE: 19.9, Growth: 19.8%) $36.34 (+62%)
Bear: (PE: 16.9, Growth: 19.8%) $30.89 (+38%)
📈 Valuation based on Current Earnings
Forward PE: 17.27 | Forward EPS (Implied): $1.30
Bull Case $27.13 (+21%)
Analyst growth 15.0%, PE expands to 18.1
Base Case $22.47 (0%)
Market implied 0.0%, PE stable at 17.3
Bear Case $17.19 (-24%)
Severe decline -15.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 21, 2026 7:46 PM ET
Data refreshes hourly during market hours. Next update: 8:46 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PRVA.

Create Free Account

Already have an account? Log In

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VEEV
Veeva Systems Inc Class A
BUY
29 analysts
$297 30 SELL
BTSG
BrightSpring Health Serv…
STRONG BUY
18 analysts
$79 51 HOLD
WAY
Waystar Holding Corp. Co…
STRONG BUY
23 analysts
$34 33 SELL
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$90 40 SELL
HNGE
Hinge Health, Inc.
STRONG BUY
17 analysts
$112 39 SELL

Advanced PRVA Option Strategies

Professional options setups generated by AI based on today's PRVA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PRVA

PRVA Technical Chart PRVA Price Prediction PRVA Earnings Date PRVA Investment Advisor PRVA Fair Price Analyzer PRVA Options Advisor PRVA Options Chain PRVA Options Analysis PRVA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals